+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • July 2022
  • 33 Pages
  • Global
From
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • May 2025
  • 250 Pages
  • Global
From
U.S. Antipsychotic Drugs Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Country - Product Thumbnail Image

U.S. Antipsychotic Drugs Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Country

  • Report
  • May 2025
  • 150 Pages
  • United States
From
Anxiety Disorders and Depression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Anxiety Disorders and Depression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • April 2025
  • 205 Pages
  • Global
From
Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 185 Pages
  • Global
Psychotropic Drug Market in China - Product Thumbnail Image

Psychotropic Drug Market in China

  • Report
  • September 2025
  • 150 Pages
  • China
From
Gabapentin Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Gabapentin Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Nassas Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Nassas Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Levomilnacipran Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Levomilnacipran Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Selective Serotonin Reuptake Inhibitor Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Selective Serotonin Reuptake Inhibitor Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Psychedelic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Psychedelic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Clonazepam Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Clonazepam Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Agoraphobia Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Agoraphobia Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Pseudobulbar Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Pseudobulbar Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Aripiprazole Drug Market in Germany - Product Thumbnail Image

Aripiprazole Drug Market in Germany

  • Report
  • March 2026
  • 161 Pages
  • Germany
From
Aripiprazole Drug Market in India - Product Thumbnail Image

Aripiprazole Drug Market in India

  • Report
  • March 2026
  • 200 Pages
  • India
From
Aripiprazole Drug Market in Canada - Product Thumbnail Image

Aripiprazole Drug Market in Canada

  • Report
  • March 2026
  • 333 Pages
  • Canada
From
Aripiprazole Drug Market in China - Product Thumbnail Image

Aripiprazole Drug Market in China

  • Report
  • March 2026
  • 372 Pages
  • China
From
Antidepressant Market in Canada - Product Thumbnail Image

Antidepressant Market in Canada

  • Report
  • February 2026
  • 153 Pages
  • Canada
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more